CBD and Liver Enzymes: FDA-Funded RCT Findings Explained
A 2025 FDA-funded randomized clinical trial found consumer-range CBD liver enzyme elevations in 5.6% of healthy adults. These elevations were reversible with no serious adverse events reported. This evidence highlights important safety considerations for…
Cannabis and Depression in Women: NHANES Study Findings
A NHANES study reveals cannabis depression gender differences, with women regular users showing nearly doubled odds of depressive symptoms. No similar association was found in men. The cross-sectional design limits causal conclusions.
Cannabis Mortality in Canada: What the Evidence Shows
The 2026 cannabis health costs in Canada include an estimated 28,000 to 30,000 premature deaths annually linked to cannabis use. This modeling study also analyzes land use policy by examining the potential benefits of reallocating cannabis farmland.…
Cannabis and Cognition in Older Adults: UK Biobank Study Review
The 2025 UK Biobank study on cannabis and cognition aging neuroscience examined cognitive performance in older adults with a history of cannabis use. Findings showed mixed associations, with some benefits and some risks linked to early and long-term use.…
Cannabis Dispensary Staff Counseling: Safety Gaps Revealed
A 2023 national survey reveals significant cannabis dispensary counseling gaps among staff, with many lacking addiction awareness. Most safety guidance comes from budtenders, not clinicians. State regulations show limited effect on counseling practices.
Medical vs. Recreational Cannabis Use: Survey Reveals Overlap
A survey of cannabis users reveals significant cannabis use psychiatric symptoms overlap between medical and recreational users. Most medical users also use recreationally, with higher daily use and psychiatric symptom rates. Only 23% had formal medical…
Cannabis Use in Older Adults: Guidance Gap After Legalization
A qualitative study highlights the older adults cannabis use guidance gap in Canada after legalization. Older adults primarily use cannabis for therapeutic reasons but face inadequate clinical support. This gap poses safety concerns and calls for better…
Thailand Cannabis Knowledge Gap: Thai Border Survey 2024
A 2024 survey at a Thai border hospital highlights cannabis health literacy Thailand, showing over 60% of participants unaware of medical uses and risks. Despite legalization awareness, knowledge gaps persist, especially among health volunteers. This…
DMT, Cannabis Dementia Risk, Valbenazine Elderly: 2025 Evidence
This 2025 review highlights cannabis dementia risk older adults alongside vaporized DMT for depression and valbenazine treatment in elderly patients. The cannabis dementia risk older adults study shows a higher dementia diagnosis rate after…
Cannabis Clinics vs GPs: Australian Patient Satisfaction Survey 2025
The 2025 Australian survey reveals significant differences in medicinal cannabis patient satisfaction between specialty cannabis clinics and generalist doctors. Patients attending cannabis clinics report lower satisfaction across multiple care dimensions…
